Page 820 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

776 INDEX INDEX

IgD antibodies, 105 fungal infections, 186 pituitary, 339 Inguinal hernia, 370
IgE antibodies, 105 Listeria monocytogenes, 139 regions susceptible to, 210 Inguinal ligament, 368, 369
ataxia-telangiectasia, 117 Pneumocystis jirovecii, 154 types of, 210 Inguinal triangle, 370
eczema, 477 Immunodeficiency syndromes IFN-β (Interferon-β) Inhalational injury, 676
hyper-IgM syndrome, 117 flow cytometry diagnosis, 54 clinical uses, 121 Inhaled anesthetics, 550
mast cells and, 408 infections in, 118 natural killer cells, 101 Inheritance modes, 59
type I hypersensitivity, 112 syndromes, 116–117 Infections Inhibin
IgG antibodies, 105 Immunoglobulin A vasculitis, 315 ESR in, 214 Sertoli cell secretion of, 628
ataxia-telangiectasia, 117 Immunoglobulins in immunodeficiency, 118 Inhibitors of complement activation,
complement activation and, 106 adaptive immunity and, 99 Inferior colliculi, 504 106
hepatitis A (HAV), 174 breast milk and, 636 Inferior gluteal nerve, 453 Inhibitory pathway, 500
multiple sclerosis, 523 isotypes of, 105 Inferior mesenteric artery, 363, 364 Injury (unintentional), 272
as passive immunity, 110 for Kawasaki disease, 314 horseshoe kidney, 579 Innate immune system
type II hypersensitivity reaction, Immunohistochemical stains, 227 Inferior oblique muscle, 540 in acute inflammation, 214
480 Immunology, 96–122 Inferior rectal artery, 366 Innate immunity, 99
type III hypersensitivity reactions, cellular components, 98 Inferior rectal vein, 365 Inositol trisphosphate (IP ), 337
3
113 immune responses, 104–117 Inferior rectus muscle, 540 Inotropes, 310
IgM antibodies, 105 immunosuppressants, 120–122 Inferior sagittal sinus, 503 Inotropy, 286
in biliary cirrhosis, 395 lymphoid structures, 96–98 Inferior vena cava, 360 INR (international normalized ratio),
complement activation and, 106 pathogen recognition in, 99 diaphragm, 663 426
hepatitis A (HAV), 174 Immunomodulator signaling gonadal drainage and, 624 Insomnia
hyper-IgM syndrome, 117 pathways, 337 Infertility barbiturates for, 546
overproduction, 431 Immunophenotype assessment, 54 clomiphene, 656 nonbenzodiazepine hypnotics, 546
in sclerosing cholangitis, 395 Immunosuppressants cystic fibrosis, 60 ramelteon for, 547
splenic dysfunction, 98 for aplastic anemia, 421 ectopic pregnancy, 641 stimulants causing, 570
Ileum, 362 targets, 121 Kallmann syndrome, 639 suvorexant, 547
basal electric rhythm, 362 transplant rejection, 120 Kartagener syndrome, 49 Inspiratory capacity (IC), 664
Ileus, 386 Immunosuppression leuprolide for, 656 Inspiratory reserve volume (IRV), 664
bacterial peritonitis (spontaneous), vitamin A deficiency, 66 mumps, 170 Insulin, 334
390 vitamin C deficiency, 69 salpingitis, 185 anabolic effects of, 334
gallstone, 396 Immunotherapy, 121 septate uterus, 623 diabetic ketoacidosis, 347
Iliacus, 452 Impaired colleague, 269 varicoceles, 651 fructose bisphosphatase-2 and, 76
Iliohypogastric nerve, 452 Imperforate hymen, 644 IFN-γ (Interferon-γ), 108, 116 GIP effect on, 371
Iliotibial band syndrome, 461 Impetigo, 136, 475 clinical uses, 121 glucagon and, 333
Illness anxiety disorder, 566 crusts with, 479 Infiltrative cardiomyopathy, 308 glycogen regulation, 73, 85
Iloperidone, 573 Imprinting disorders, 58 Inflammasome, 214 hypokalemia from, 590
Imatinib, 433, 443 Inactivated (killed) vaccine, 111 Inflammation potassium shifts wit, 590
IMG registration timeframe, 6 Incidence vs prevalence, 259 acute, 214 in pregnancy, 334
Imipenem in medical error corrections, 259 in atherosclerosis, 302 production of, 329
seizures with, 251 Inclusions cardinal signs, 213 secretion of, 334
Imipramine, 575 Cowdry A, 166 chronic, 216 somatostatin and, 371
Immature ego defenses, 555 mulberry-like (morulae), 150 ESR in, 214 somatostatinomas and, 351
Immature teratoma, 647 Negri bodies, 171 Extrinsic (death receptor) pathway, Insulin deficiency, 590
Immune checkpoint interactions, “owl eye,” 165 208 diabetes mellitus diagnosis, 346
222 reticulate bodies, 148 IL-1 in, 108 Insulin-like growth factor 1 (IGF-1)
Immune complex, 113 Incomplete penetrance, 56 Intrinsic (mitochondrial) pathway, acromegaly, 339
Immune evasion Incontinence (fecal/urinary), 453 208 signaling pathways for, 337
in cancer, 221 Incus, 533, 620 wound healing, 216 Insulinoma, 351
Immune responses Incus (ossicles) Inflammatory bowel disease (IBD), insulin and C-peptide in, 334
acute-phase reactants, 102 pharyngeal arch derivative, 620 382 MEN 1 syndrome, 351
antibody structure and function, India ink stain, 125 azathioprine for, 440 pancreatic cell tumor, 351
104–117 Indicator media, 126 colorectal cancer and, 388 Insulin preparations, 352
antigen type and memory, 105 Indinavir erythema nodosum, 482 Insulin resistance, 633
Bordetella pertussis, 143 HIV therapy, 203 infliximab/adalimumab for, 487 acanthosis nigricans and, 482
cell surface proteins, 110 Indirect bilirubin, 375 methotrexate for, 440 acromegaly, 339
complement, 106 Indirect cholinomimetic agonists, 240 sclerosing cholangitis and, 395 cortisol, 336
cytokines, 108 Indirect Coombs test spondyloarthritis, 469 DM type 2, 347
hypersensitivity types, 114–115 unbound antibody detection, 112 therapeutic antibodies, 122 GH, 329
immunoglobulin, 105 Indirect inguinal hernia, 370 Inflammatory breast disease, 649, 650 non-alcoholic fatty liver disease,
passive vs active, 110 Indirect sympathomimetics, 242 Inflammatory demyelinating 391
respiratory burst, 109 Indirect (unconjugated) polyradiculopathy, 524 polycystic ovarian syndrome, 645
Salmonella/Shigella spp, 144 hyperbilirubinemia, 393 Infliximab, 122, 487 Insurance
transfusion reactions, 114 Indomethacin, 486 for Crohn disease, 382 disregarding in treatment, 269
Immune system organs for diabetes insipidus, 338 for ulcerative colitis, 382 Medicare/Medicaid as, 272
cellular components, 99 IFN-α (Interferon-α) Influenza, 169 types of plans, 271
lymph nodes, 96 clinical uses, 121 orthomyxovirus, 167 Integrase inhibitors, 203
thymus, 98 myopathy, 250 pneumonia, 683 Integrins
Immunocompromised patients natural killer cells, 101 treatment/prevention, 201 epithelial cells, 474
acyclovir/famciclovir/valacyclovir, Infant development, 635 Informed consent, 265 viral receptor, 166
201 Infarction Infraspinatus muscle Intellectual disability, 557
Candida albicans in, 153 blood-brain barrier effects, 496 Erb palsy, 448 autism and, 557
common organisms affecting, 179 of bone, 463 rotator cuff, 446 cri-du-chat syndrome, 64
Cryptococcus neoformans, 153 Infarcts Infundibulopelvic ligament, 625 Down syndrome, 63
Cryptosporidium, 155 atherosclerosis, 302 Ingested seafood toxins, 247 Lesch-Nyhan syndrome, 37
esophagitis in, 377 calcification in, 211 Inguinal canal, 369 Patau syndrome, 63

FAS1_2019_21_Index_749-806.indd 776 11/21/19 12:27 PM